Behavior of antithrombin III isoforms on immobilized heparins. Evidence that the isoforms bind to different numbers of low-affinity heparin sites.

Carlson, Timothy H.; Babcock, T; Atencio, A C; Levinson, Charles; Mora, H R

doi:10.1016/s0021-9258(18)69189-6

Cited by 10 publications

(1 citation statement)

References 46 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…AT III is an alpha two globin molecule found in the blood which slowly neutralizes thrombin in-situ (5). In the presence of heparin, this activity is increased by 1,000 (6).…”

mentioning

confidence: 99%

The Role of Antithrombin III in Heparin Resistance

Rivard,

Thompson,

Cameron

1990

J Extra Corpor Technol

View full text Add to dashboard Cite

Resistance to the anticoagulation action of sodium heparin during cardiopulmonary bypass is a serious concern and a poorly understood phenomenon. In the majority of cases, the desired prolongation of the activated clotting time (ACT) is achieved by administration of additional heparin. A patient's previous exposure to heparin has been suggested as the cause of this clinical dilemma. The administration of fresh frozen plasma to patients who demonstrated a heparin resistance have been shown to produce a normalization of their heparin/ACT dose response curve and a decrease in total heparin requirements during cardiopulmonary bypass. These results could be an indication of a deficiency of a component in patient's plasma. This study was designed to compare antithrombin III (AT III) in two patient populations. Group A consisted of 15 patients receiving intravenous heparin therapy prior to cardiopulmonary bypass for greater than 24 hours. Population B included 15 patients who had not been exposed to heparin therapy preoperatively. All patients were candidates for coronary artery bypass grafting. The quantitative assay utilized the Loyal Rocket Immunoelectrophoresis Technique and the qualitative assay was determined by the AT III Anti-10A Activity Assay. Two sample t-test analyses of variance revealed no statistical significance (p<0.05) between the two populations in either quantitative assay (p=0.054) or the qualitative assay (p=0.06). A comparison of the ration (qualitative/quantitative) showed a statistical difference (p=0.016). It can be suggested from these results that the resistance to heparin demonstrated in heparin therapy patients is the result of a combination of factors associated with AT III. Administration of heparin decreases the available AT III and decreases its function. The combination of these two factors contributes to this resistance phenomenon.

show abstract

“…AT III is an alpha two globin molecule found in the blood which slowly neutralizes thrombin in-situ (5). In the presence of heparin, this activity is increased by 1,000 (6).…”

mentioning

confidence: 99%